Médecine

Paramédical

Autres domaines


S'abonner

Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level - 30/05/20

Doi : 10.1016/j.biopha.2020.110147 
Jun Xie a, 1, Wei Song b, 1, Xiaochun Liang a, , Qian Zhang a, Yue Shi a, Wei Liu a, Xiaohu Shi a
a Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China 
b Center for Translational Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China 

Corresponding author at: Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730 China.Department of Traditional Chinese MedicinePeking Union Medical College HospitalNo.1 ShuaifuyuanDongcheng DistrictBeijing100730China

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

pages 14
Iconographies 11
Vidéos 0
Autres 0

Graphical abstract

Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes with no effective drug currently. Quercetin is a natural bio-flavonoid widely distributed in the human diet. As an effective antioxidant for reactive oxygen species (ROS) protection, quercetin’s protective effects against diabetes, inflammation, and nerve damage have been extensively documented. However, the mechanism of its neuroprotective function and the link to the gut microbiota remains to be elucidated.

The present study investigated the relationship between the therapeutic effect and the modulation of gut microbiota of quercetin in DPN rats. The current results indicate that quercetin might exert a peripheral neuroprotective effect in DPN rats by modulating the gut microbial dysbiosis through decreasing the abundance of potential pathogenic bacterias, such as f_Porphyromonadaceae, f_Oxalobacteraceae, g_Oxalobacter and g_Klebsiella, which were positively correlated with DPN phenotypes and ROS production levels; while enriching the potential ‘probiotics’ bacterial taxa, such as p_Actinobacteria and c_Actinobacteria, which were negatively correlated with DPN phenotypes and ROS production levels. These target microbiota species might help ameliorate the oxidant stress that caused myelin and axon damage accompanied with up-regulated amyloid precursor protein (APP) and ionized calcium binding adaptor molecule 1 (Iba1) expressions and down-regulated percentage of contactin-associated protein (Caspr)-expressing paranodes in the sciatic nerves of DPN rats. Meanwhile, the balanced gut microbiota might help improve protein gene product 9.5 (PGP9.5)-positive intraepidermal nerve fiber densities in the plantar skin of DPN rats. The protected sciatic nerves and increased intraepidermal nerve fiber densities might contribute to the improved peripheral nerve functions after quercetin treatment.




Le texte complet de cet article est disponible en PDF.

Highlights

Quercetin significantly ameliorated the phenotypes and decreased the ROS production levels in DPN rats.
Quercetin was firstly found to modulate gut microbiota in DPN rats.
The modulated gut microbiota species were correlated to the DPN phenotypes and ROS production levels in DPN rats.

Le texte complet de cet article est disponible en PDF.

Abstract

Objective

Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes with no effective drug currently. As a powerful antioxidant, the flavonoid quercetin has been demonstrated to have potential neuroprotective and prebiotic capacity. But the mechanism of its neuroprotective function and the link to the gut microbiota remains to be elucidated.

Methods

The neuroprotective effect of quercetin was evaluated on streptozotocin(STZ)-induced DPN rats through electrophysiology, behavioristic, and pathomorphology studies. Serum and urine reactive oxygen species (ROS) production levels and fecal gut microbiota compositions were detected, and the relationship between them was analyzed by Spearman’s correlation.

Results

Quercetin not only reversed the decreased mechanical withdraw thresholds and intraepidermal nerve fiber densities in DPN rats, but also improved neurological morphology of sciatic nerves, accompanied with up-regulated percentage of paranodes at paranodal junctions, and down-regulated amyloid precursor protein and ionized calcium-binding adaptor molecule 1 in DPN rats. More importantly, quercetin rescued gut dysbiosis in DPN rats by decreasing four potential pathogenic species and enriching two prebiotic species associated with DPN phenotypes and ROS production levels.

Conclusions

Quercetin exerts neuroprotective effect and modulates gut microbiota associated with DPN phenotypes and ROS production levels in STZ-induced DPN rats, suggesting the therapeutic application of quercetin for DPN prevention and treatment.

Le texte complet de cet article est disponible en PDF.

Abbreviations : DPN, ROS, STZ, NIH, MWT, MNCV, PBS, PFA, ELISA, GSH, GSSG, SOD, MDA, HE, Caspr, APP, βIII-tubulin, Iba-1, IENFD, PGP 9.5, LEfSe, PCoA

Keywords : Diabetic peripheral neuropathy, Diabetic rats, Gut microbiota, Reactive oxygen species, Quercetin


Plan


© 2020  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 127

Article 110147- juillet 2020 Retour au numéro
Article précédent Article précédent
  • Myricetin against myocardial injury in rat heat stroke model
  • Xiaojing Lin, Cheng-Hsien Lin, Ruoxu Liu, Chenyi Li, Shuxin Jiao, Xueqing Yi, M.J. Walker, Xiao-Ming Xu, Tingbao Zhao, Po-Chang Huang, Gang Sun
| Article suivant Article suivant
  • Topical co-administration of Teucrium polium hydroethanolic extract and Aloe vera gel triggered wound healing by accelerating cell proliferation in diabetic mouse model
  • Morteza Najaf zadeh Gharaboghaz, Mohammad Reza Farahpour, Shahram Saghaie

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.